We are monitoring the impact of COVID-19 on MEA Point Of Care Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Point of Care (POC) Diagnostics/Testing Market Research Report – Segmented By Product, End-User, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1485
Pages: 135

MEA Point of Care (POC) Diagnostics/Testing Market Size (2022 to 2027)

The size of the Point of Care (POC) Diagnostics/Testing Market in the Middle East & Africa was worth USD 1.99 billion in 2022 and estimated to reach USD 3.12 billion by the end of 2027 with a CAGR of 9.42%.

With the development of miniaturized devices and integration with wireless technology, healthcare professionals can maintain electronic medical records and provide personalized intervention for patients. This allows for better data collection with a lesser risk for discrepancies in the test results obtained. This is driving the MEA POC diagnostics market, increased healthcare spending, and a high prevalence of cancer, diabetes, and other diseases. According to the report published by a network of civil society organizations, it was reported that South Africa was experiencing an increase in noncommunicable diseases, such as heart disease, stroke, diabetes, and others. This increase in the condition in the African region will create high demand for diagnostics. According to the International Diabetes Federation, 17 million adults between the ages of 20 and 79 are expected to have diabetes in the IDF African region in 2018, representing a prevalence of 3.6% in the whole area.

The UAE and South Africa are the major MEA countries that are driving the market. Factors such as the availability of quality healthcare and high incidences of noncommunicable diseases are driving the market's growth. According to the World Cancer Registry, around 4,500 new cancer cases will be diagnosed in the UAE in 2020. Furthermore, according to the Atlas 2020 of the International Diabetes Federation, the prevalence of diabetes is estimated at 1.30 million in the United Arab Emirates. The disease has been observed frequently in the mid- older age groups. In addition, the advent of home cancer screening kits, which can actively monitor and analyze tumor cells, improved research and development to develop diagnostic applications, and increased healthcare awareness are anticipated to drive the MEA POC diagnostics market growth during the forecast period.

However, the key restraining factor affecting the market negatively is the lack of reimbursement policies for the POC diagnostic kits in the MEA region.

This research report on the MEA POC diagnostics market has been segmented and sub-segmented into the following categories.

By Product: 

  • Infectious Diseases
  • Cardiac Markers
  • Oncology Markers
  • OTC Diagnostic Tests
  • Drugs Of Abuse
  • Blood Gas Testing
  • Fertility Testing
  • Urinalysis
  • Coagulation
  • Hematology
  • Glucose Monitoring
  • Ambulatory Chemistry
  • Decentralized Clinical Chemistry 

By End-User: 

  • Clinics
  • Hospitals
  • Home Healthcare
  • Ambulatory Care Settings
  • Laboratories

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The UAE is projected to dominate the MEA market during the forecast period, owing to government initiatives to control the prevalence of diabetes in the region to 17% by increasing awareness. In addition, advanced hospitals, especially in the major cities, will drive the healthcare sector in UAE to maintain its position as the major shareholder.

Saudi Arabia is forecasted to register the highest CAGR for point-of-care diagnostics in this region during the forecast period. This is because this region’s healthcare system has grown rapidly in recent years. This growth may be due to the growing wealth of the country and advanced quality of health care with good insurance options for their residents. In addition, among the significant MEA countries, Saudi Arabia has seen substantial growth in the diagnostics industry over the years. Hence, these factors will help the regional market.

In the African region, the South African market is expected to grow at a healthy CAGR of 5.5% during the forecast period. This can be attributed to increasing diseases such as HIV / AIDS, diabetes, malaria, etc. According to WHO reports, diabetes is expected to reach 24 million cases by 2030. Authorities estimate that the diabetic population could double over the next 20 years in the African region. Therefore, the increasing prevalence of the disease is expected to drive the growth of PC diagnostics in the area. But due to poor economies and lack of adequate healthcare facilities, the region will see slow growth during the forecast period. However, factors such as an increase in government aid to educate people with early diagnosis, the lifestyle change, and rise in funds for proper healthcare facilities added with free medical camps help overall development. It is estimated that these activities drive the demand for the point-of-care diagnostics market in Africa, thereby boosting the MEA point-of-service diagnostics market.

KEY MARKET PLAYERS:

Companies such as Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics are playing a pivotal role in the MEA Point of Care (POC) Diagnostics/Testing Market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Infectious Diseases             

                                5.1.3 Cardiac Markers   

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests          

                                5.1.6 Drugs Of Abuse    

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing     

                                5.1.9 Urinalysis 

                                5.1.10 Coagulation         

                                5.1.11 Hematology         

                                5.1.12 Glucose Monitoring          

                                5.1.13 Ambulatory Chemistry    

                                5.1.14 Decentralized Clinical Chemistry 

                                5.1.15 Others   

                                5.1.16 Y-o-Y Growth Analysis, By Product              

                                5.1.17 Market Attractiveness Analysis, By Product            

                                5.1.18 Market Share Analysis, By Product             

                5.2 End-Users                   

                                5.2.1 Introduction           

                                5.2.2 Clinics        

                                5.2.3 Hospitals  

                                5.2.4 Home Healthcare 

                                5.2.5 Ambulatory Care Settings 

                                5.2.6 Laboratories           

                                5.2.7 Others      

                                5.2.8 Y-o-Y Growth Analysis, By End-Users           

                                5.2.9 Market Attractiveness Analysis, By End-Users          

                                5.2.10 Market Share Analysis, By End-Users        

                5.3 Mode of Delivery                     

                                5.3.1 Introduction           

                                5.3.2 OTC            

                                5.3.3 Prescription            

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery             

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery            

                                5.3.6 Market Share Analysis, By Mode of Delivery             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By End-Users

                                                6.1.3.4 By Mode of Delivery

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By End-Users

                                                6.1.4.4 By Mode of Delivery

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By End-Users

                                                6.1.5.4 By Mode of Delivery

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Roche Diagnostics                    

                8.4 BioMerieux                

                8.5 Siemens Healthcare                

                8.6 Beckman Coulter                     

                8.7 Becton Dickinson and Company                        

                8.8 Johnson & Johnson                 

                8.9 Johnson & Johnson                 

                8.10 PTS Diagnostics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

 

  1. Middle East & Africa Point-of-Care Diagnostics Market By Application, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Infectious Diseases Market By Region, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Cardiac Markers Market By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Oncology Markers Market By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa OTC Diagnostic Tests Market By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Drugs Of Abuse Market By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Blood Gas Testing Market By Region, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Fertility Testing Market By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Urinalysis Market By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Coagulation Market By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Hematology Market By Region, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa Glucose Monitoring Market By Region, From 2022 - 2027 (USD Billion)
  13. Middle East & Africa Ambulatory Chemistry Market By Region, From 2022 - 2027 (USD Billion)
  14. Middle East & Africa Decentralized Clinical Chemistry Market By Region, From 2022 - 2027 (USD Billion)
  15. Middle East & Africa Others Market By Region, From 2022 - 2027 (USD Billion)
  16. Middle East & Africa Point-of-Care Diagnostics Market By End-Users, From 2022 - 2027 (USD Billion)
  17. Middle East & Africa Clinics Market By Region, From 2022 - 2027 (USD Billion)
  18. Middle East & Africa Hospitals Market By Region, From 2022 - 2027 (USD Billion)
  19. Middle East & Africa Home Healthcare Market By Region, From 2022 - 2027 (USD Billion)
  20. Middle East & Africa Ambulatory Care Settings Market By Region, From 2022 - 2027 (USD Billion)
  21. Middle East & Africa Laboratories Market By Region, From 2022 - 2027 (USD Billion)
  22. Middle East & Africa Others Market By Region, From 2022 - 2027 (USD Billion)
  23. Middle East & Africa Point-of-Care Diagnostics Market By Mode of Delivery, From 2022 - 2027 (USD Billion)
  24. Middle East & Africa OTC Market By Region, From 2022 - 2027 (USD Billion)
  25. Middle East & Africa Prescription Market By Region, From 2022 - 2027 (USD Billion)
  26. Middle East Point-of-Care Diagnostics Market By Application, From 2022 - 2027 (USD Billion)
  27. Middle East Point-of-Care Diagnostics Market By End-Users, From 2022 - 2027 (USD Billion)
  28. Middle East Point-of-Care Diagnostics Market By Mode of Delivery, From 2022 - 2027 (USD Billion)
  29. Africa Point-of-Care Diagnostics Market By Application, From 2022 - 2027 (USD Billion)
  30. Africa Point-of-Care Diagnostics Market By End-Users, From 2022 - 2027 (USD Billion)
  31. Africa Point-of-Care Diagnostics Market By Mode of Delivery, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample